ATRX - Top Stocks Targeting the Underserved $5.7B Parkinson's Opportunity (PRTA ITCI ATRX QURE GMAB IMPL AMRX)
According to a recent report from MarketsAndMarkets.com, the global Parkinson’s disease treatment market is expected to reach $5.69 billion by 2022, growing from $4.24 billion in 2017, expanding at a CAGR of 6.1%. The report notes that this market is being driven by rising geriatric population and expanding government funding for research on the disease. […]
For further details see:
Top Stocks Targeting the Underserved $5.7B Parkinson’s Opportunity (PRTA, ITCI, ATRX, QURE, GMAB, IMPL, AMRX)